Evaluation of the Responsiveness of Investigator Global Assessment Score for Keratosis
This prospective study aims to evaluate the responsiveness of the validated investigator global assessment (IGA) and composite area index score for keratosis pilaris by data collection through treatment and scoring sessions held at a private practice and relevant statistical analysis.
Validation of 5-Point Investigator Global Assessments for Pemphigus
This study aims to explore the reliability and validity of newly developed Investigator Global Assessments (IGAs) in scoring the severity of pemphigus. IGAs are simple 5-point scales ranging from clear - severe and are preferred by the FDA as endpoints in clinical trials.
Development and Validation of an Investigator Global Assessment Score for Keratosis Pilaris
This validation study aims to develop a standardised investigator global assessment (IGA) score for keratosis pilaris and test the validity and reliability of the score through a one-day scoring exercise held at a private practice and compare it to a standard 0-4 IGA score specifically defined for keratosis pilaris.
100 Clinical Results associated with Premier Villages Ltd.
0 Patents (Medical) associated with Premier Villages Ltd.
100 Deals associated with Premier Villages Ltd.
100 Translational Medicine associated with Premier Villages Ltd.